Roth Capital Downgrades Recro Pharma (REPH) to Neutral, Will Await NT Strategy Disclosure Mar 25, 2019 08:10AM
Recro Pharma (REPH) PT Raised to $15 at Roth Capital Nov 7, 2018 11:46AM
Recro Pharma (REPH) PT Lowered to $8.50 at Roth Capital May 25, 2018 06:51AM
Recro Pharma Announces Closing of $40 Million Public Offering of Common Stock Dec 16, 2016 09:27AM
Recro Pharma (REPH) Prices 6.5M Shares at $6/Share Dec 13, 2016 09:12AM


Dec 13, 2016 09:10AM Recro Pharma Announces Pricing of Public Offering of Common Stock
Sep 16, 2016 08:45AM Roth Capital Starts Recro Pharma (REPH) at Buy
Aug 29, 2016 10:16AM Notable Analyst Rating Changes 8/29: (CBL) (ATI) (KS) Upgraded; (HAYN) (KEY) (SQ) Downgraded
Mar 10, 2015 01:05PM Unusual 11 Mid-Day Movers 3/10: (CASI) (REPH) (JOB) Higher; (NNBR) (IDT) (TITN) Lower